Showing 25,241 - 25,260 results of 69,501 for search '(( 50 ((a decrease) OR (nn decrease)) ) OR ( a ((point decrease) OR (mean decrease)) ))', query time: 0.87s Refine Results
  1. 25241

    Table 1_A population database analysis to describe the residual burden of varicella in Italy—a high vaccination coverage area—from 2004 to 2022.docx by Elisa Barbieri (115023)

    Published 2025
    “…In the Veneto Region, following the implementation of VV in 2006, the IR significantly decreased by 20.5 annually (95% CI: −23.4, −17.5), ranging from 50.2 per 1,000 person-years in 2006 to 1.2 per 1,000 person-years in 2022.…”
  2. 25242
  3. 25243

    Image1_CGX, a standardized herbal syrup, inhibits colon-liver metastasis by regulating the hepatic microenvironments in a splenic injection mouse model.DOCX by Sung-Bae Lee (6835907)

    Published 2022
    “…<p>Background: Colon-liver metastasis is observed in approximately 50% of patients with colorectal cancer and is a critical risk factor for a low survival rate. …”
  4. 25244

    Image1_CGX, a standardized herbal syrup, inhibits colon-liver metastasis by regulating the hepatic microenvironments in a splenic injection mouse model.tif by Sung-Bae Lee (6835907)

    Published 2022
    “…<p>Background: Colon-liver metastasis is observed in approximately 50% of patients with colorectal cancer and is a critical risk factor for a low survival rate. …”
  5. 25245

    [<sup>11</sup>C]CHIBA-1001 as a Novel PET Ligand for α7 Nicotinic Receptors in the Brain: A PET Study in Conscious Monkeys by Kenji Hashimoto (36400)

    Published 2008
    “…Interestingly, the binding of [<sup>11</sup>C]CHIBA-1001 in the frontal cortex of the monkey brain was significantly decreased by subchronic administration of the N-methyl-D-aspartate (NMDA) receptor antagonist phencyclidine (0.3 mg/kg, twice a day for 13 days); which is a non-human primate model of schizophrenia.…”
  6. 25246
  7. 25247

    A quantitative exploration of gastrointestinal bleeding in intensive care unit patients by Patrick C. Eschenfeldt (5434739)

    Published 2019
    “…To demonstrate this method, we compare patients’ standard vital signs while bleeding heavily to times when they are not bleeding, finding a 3.0 ± 0.5% increase in heart rate, a 1.3 ± 0.4% decrease in systolic blood pressure and a 0.9 ± 0.5% decrease in diastolic blood pressure. …”
  8. 25248
  9. 25249
  10. 25250
  11. 25251

    Table_1_Osteoporosis: a problem still faulty addressed by the Romanian healthcare system. Results of a questionnaire survey of people aged 40 years and over.pdf by Narcisa Jianu (19931601)

    Published 2024
    “…Moreover, participants already diagnosed with osteoporosis did not show a better disease knowledge than those without a diagnosis. …”
  12. 25252

    Table_1_Osteoporosis: a problem still faulty addressed by the Romanian healthcare system. Results of a questionnaire survey of people aged 40 years and over.pdf by Narcisa Jianu (19931601)

    Published 2024
    “…Moreover, participants already diagnosed with osteoporosis did not show a better disease knowledge than those without a diagnosis. …”
  13. 25253
  14. 25254

    A simulation showing the effect of anti-PCSK9 antibodies therapy. by Yuri Efremov (11450672)

    Published 2022
    “…The binding of PCSK9 with antibodies prevents its binding with LDLR and leads to the decrease in LDL/VLDL levels. [<a href="http://www.plosone.org/article/info:doi/10.1371/journal.pone.0264903#pone.0264903.ref018" target="_blank">18</a>].…”
  15. 25255
  16. 25256
  17. 25257

    The impact of a breast cancer diagnosis on health-related quality of life. A prospective comparison among middle-aged to elderly women with and without breast cancer by Randi V. Karlsen (2545756)

    Published 2016
    “…</p> <p><b>Material and methods</b> The Danish Diet, Cancer and Health study included 57 053 cancer-free persons aged 50–64 years at baseline (1993–1997). We used data from first follow-up (1999–2002) and second follow-up (2010–2012) on HQoL [Medical Outcomes Survey, short form (SF-36)] obtained from 542 women aged 64–82 years with primary breast cancer (stages I–III) and a randomly matched sample of 729 women who remained breast cancer-free. …”
  18. 25258
  19. 25259
  20. 25260